Results 61 to 70 of about 8,581 (204)
Respiratory Medicine Case Reports, 2019 Introduction: Pulmonary alveolar proteinosis is a rare disease that is characterized by accumulation of surfactant and phospholipids in the pulmonary alveoli. The current mainstay of treatment is whole lung lavage.
Haiyan Zhang
doaj +1 more source
Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies
Frontiers in Immunology, 2023 Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder that is characterized by the abnormal accumulation of surfactant within the alveoli. Alveolar macrophages (AMs) have been identified as playing a pivotal role in the pathogenesis of PAP ...
Xinmei Huang +7 more
doaj +1 more source
Pulmonary alveolar proteinosis - a case report [PDF]
, 2014 Efst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinnPróteinútfellingar í lungnablöðrum (pulmonary alveolar proteinosis, PAP) eru oftast af óþekktum orsökum en meingerð sjúkdómsins er rakin til skertrar átfrumuvirkni í ...
Eyþór Björnsson +7 more
core
From the definition of Silicosis at the 1930 Johannesburg conference to the blurred boundaries between pneumoconioses, sarcoidosis and pulmonary alveolar proteinosis (PAP) [PDF]
, 2015 The 1930 International Labour Office Conference on silicosis in Johannesburg identified silicosis by setting a medicolegal framework to its nosology: as with other occupational illnesses, its medical content was fixed under economic pressure.
Catinon, Mickaël +4 more
core +1 more source
Respirology, Volume 31, Issue 1, Page 53-61, January 2026.ABSTRACT Background and Objective Interstitial lung diseases (ILDs) are rare and severe respiratory conditions that may ultimately result in pulmonary fibrosis (PF). The objective of this study was to present the results of molecular diagnosis of early‐onset ILD (from neonates to young adults < 50 years) in a reference genetic diagnostic laboratory ...
Camille Louvrier +20 more
wiley +1 more source
Pulmonary alveolar proteinosis after lung transplantation
Respirology Case Reports, 2020 We report the case of a 69‐year‐old man five‐month post double lung transplant for idiopathic pulmonary fibrosis (IPF) who presented with progressive breathlessness, loss of lung function, and diffuse ground glass shadowing on the chest computed ...
Chandima Divithotawela +4 more
doaj +1 more source
Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework [PDF]
, 2017 Background The accumulation of MWCNTs in the lung environment leads to inflammation and the development of disease similar to pulmonary fibrosis in rodents.
Banville, Allyson +8 more
core +1 more source
Clinical Case Reports, Volume 13, Issue 12, December 2025.CT of the Chest demonstrated bilateral ground‐glass opacities. ABSTRACT We describe an elderly woman with systemic lupus erythematosus (SLE) who presented with dyspnoea, anemia, and bilateral pulmonary infiltrates initially diagnosed as community‐acquired pneumonia.
Abu Bocus +3 more
wiley +1 more source
Orphanet Journal of Rare Diseases, 2007 Background Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of lipoproteinaceous material within alveoli, occurring in three clinically distinct forms: congenital, acquired and secondary.
Baritussio Aldo +7 more
doaj +1 more source
Pulmonary alveolar proteinosis, unusual infiltrative lung disease, the dilemma for physicians: A case report and literature review [PDF]
Journal of Analytical Research in Clinical Medicine, 2017 Introduction: Pulmonary alveolar proteinosis (PAP) is a diffuse pulmonary disease characterized by the intra-alveolar accumulation of formless, proteinaceous material.
Ali Ghavidel
doaj +1 more source